These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28266813)

  • 1. Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.
    Hwang EC; Jung SI; Lee HJ; Lee JJ; Kwon DD
    Int Braz J Urol; 2017; 43(4):615-627. PubMed ID: 28266813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells.
    Hwang EC; Lim MS; Im CM; Kwon DD; Lee HJ; Nguyen-Pham TN; Lee YK; Lee JJ
    Scand J Immunol; 2013 Feb; 77(2):117-24. PubMed ID: 23126536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
    Yang DH; Kim MH; Lee YK; Hong CY; Lee HJ; Nguyen-Pham TN; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
    Ann Hematol; 2011 Dec; 90(12):1419-26. PubMed ID: 21465188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.
    Park MH; Yang DH; Kim MH; Jang JH; Jang YY; Lee YK; Jin CJ; Pham TN; Thi TA; Lim MS; Lee HJ; Hong CY; Yoon JH; Lee JJ
    Cancer Res Treat; 2011 Mar; 43(1):56-66. PubMed ID: 21509164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.
    Yang DH; Kim MH; Hong CY; Lee YK; Jin CJ; Pham TN; Ahn JS; Bae WK; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
    Ann Hematol; 2010 Aug; 89(8):795-801. PubMed ID: 20238114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.
    Hansen M; Hjortø GM; Donia M; Met Ö; Larsen NB; Andersen MH; thor Straten P; Svane IM
    Vaccine; 2013 Jan; 31(4):639-46. PubMed ID: 23200882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia.
    Lee JJ; Foon KA; Mailliard RB; Muthuswamy R; Kalinski P
    J Leukoc Biol; 2008 Jul; 84(1):319-25. PubMed ID: 18426971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
    Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
    World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.
    Kim YH; Tran TA; Lee HJ; Jung SI; Lee JJ; Jang WY; Moon KS; Kim IY; Jung S; Jung TY
    Oncotarget; 2016 Aug; 7(31):50535-50547. PubMed ID: 27409668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.
    Wieckowski E; Chatta GS; Mailliard RM; Gooding W; Palucka K; Banchereau J; Kalinski P
    Prostate; 2011 Feb; 71(2):125-33. PubMed ID: 20717900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
    Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.
    Mailliard RB; Wankowicz-Kalinska A; Cai Q; Wesa A; Hilkens CM; Kapsenberg ML; Kirkwood JM; Storkus WJ; Kalinski P
    Cancer Res; 2004 Sep; 64(17):5934-7. PubMed ID: 15342370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile.
    Gustafsson K; Junevik K; Werlenius O; Holmgren S; Karlsson-Parra A; Andersson PO
    Scand J Immunol; 2011 Sep; 74(3):318-326. PubMed ID: 21595737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.
    Kumar J; Kale V; Limaye L
    Stem Cell Res Ther; 2015 Sep; 6():184. PubMed ID: 26407613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type-1 polarised dendritic cells are a potent immunogen against
    Satake Y; Nakamura Y; Kono M; Hozumi H; Nagata T; Tsujimura K; Enomoto N; Fujisawa T; Inui N; Fujiyama T; Tokura Y; Matsui T; Yokomura K; Shirai M; Hayakawa H; Suda T
    Int J Tuberc Lung Dis; 2017 May; 21(5):523-530. PubMed ID: 28399967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic T lymphocytes having increased homing signals to cancer.
    Hong CY; Kim SY; Lee HJ; Lee SE; Lim SC; Rhee JH; Lee JJ
    J Immunother; 2014 Jan; 37(1):16-25. PubMed ID: 24316552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of potent dendritic cells with improved migration ability through p-cofilin and sarco/endoplasmic reticulum Ca(2+) transport ATPase 2 regulation.
    Choi NR; Lee HJ; Jung SH; Hong CY; Vo MC; Hoang MD; Kim HJ; Lee JJ
    Cytotherapy; 2015 Oct; 17(10):1421-33. PubMed ID: 26212610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.